Retraction notices

Sensitizing Estrogen Receptor–negative Breast Cancer Cells to Tamoxifen with OSU-03012, a Novel Celecoxib-derived Phosphoinositide-dependent Protein Kinase-1/Akt Signaling Inhibitor

Type
Retraction
Notice date
4/1/2019 0:00
Journal
Molecular Cancer Therapeutics
Publisher
American Association for Cancer Research
Notice DOI
10.1158/1535-7163.mct-19-0151
Original paper DOI
10.1158/1535-7163.mct-07-0434

Reasons

Matching venue names

Name match only, not an authoritative journal identifier.